Clin2
NCT07528027Possibly a fitRecruiting

Study of a new drug for high blood pressure with overweight or obesity

Hypertension With Overweight or Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests a new medication called HRS-7535 for people who have high blood pressure and are also overweight or obese. The drug may help lower blood pressure and support weight loss, and this trial will compare it to a placebo to see if it works well and is safe.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
648 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • Your blood pressure is moderately high but not extremely high (systolic 140–169 or diastolic 90–109).
  • You are either not on blood pressure medication, or you are on a stable dose of common blood pressure drugs.
  • Your body mass index (BMI) is 24 or higher.
  • You do not have high blood pressure caused by another condition, recent heart surgery, type 1 diabetes, or pancreatitis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06820099Recruiting· Phase 2
A drug for heart failure with obesity

This trial tests an oral drug called HRS-7535 for people with a certain type of heart failure (where the heart pumps normally but doesn't relax properly) and who also have obesity. It aims to see if the drug can improve symptoms and daily function.

Beijing, Beijing Municipality
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT06830343Recruiting· Phase 1
Safety study of SYH9017 for overweight and obesity

This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.

Beijing, Beijing Municipality
NCT06974851Recruiting· Phase 3
Study of HRS9531 for sleep apnea and obesity

This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.

Beijing, Beijing Municipality
NCT07708441Not yet recruiting· Phase 2/Phase 3
Study of an experimental drug for hard-to-treat high blood pressure

This study tests an investigational drug called HRS-1780 for people with high blood pressure that is not well controlled or is resistant to treatment. The purpose is to see if it can lower blood pressure more effectively than current options.

Chongqing, Chongqing Municipality
NCT07150962Recruiting· Phase 1
Testing a new version of an obesity treatment pill

This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.

Hefei, Anhui

Hear when a new Hypertension With Overweight or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.